CorMedix Inc. cotiza a 7.46 USD y tiene una capitalización bursátil de $581M. En los últimos 12 meses ha facturado $462M con un margen de flujo de caja libre del 55.4%. Cotiza a 2.3 veces su flujo de caja libre (P/FCF) y a un PER de 3.1. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infection…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $0.35 | $0.16 |
| Estimado | $0.01 | $0.27 | $0.33 | $0.81 |
| Sorpresa | — | — | +6.1% | -80.2% |
| Métrica | CRMD | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 88.5% | 57.0% | +31.4% |
| Operating Margin | 48.2% | -38.6% | +86.8% |
| Net Margin | 52.3% | -33.6% | +85.9% |
| FCF Margin | 55.4% | -13.9% | +69.3% |
| ROE | 40.2% | -40.4% | +80.6% |
| ROA | 19.7% | -32.0% | +51.8% |
| Current Ratio | 2.11 | 2.84 | -0.73 |
| Debt / Equity | — | 0.28 | — |